Trials / Completed
CompletedNCT02824744
Comparison Between 2l vs 3l in HFNC During the Initial Management of Severe Bronchiolitis in Infants
Comparison Between 2l/Min/kg vs 3l/Min/kg in High Flow Nasal Cannula (HFNC) During the Initial Management of Severe Bronchiolitis in Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 0 Hours – 6 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate prospectively the clinical benefits of 2 different flow with High flow nasal canula (HFNC: 2l/kg/min) versus (HFNC: 2l/kg/min) in the initial management of bronchiolitis in infants. Design: Prospective, controlled, randomized, multi-center. Design: Infants less than 6 month admitted in pediatric intensive care unit for respiratory distress (mWCAS \>3) secondary to bronchiolitis but not requiring mechanical ventilation will be randomized in two groups:HFNC "2l/min/kg" or HFNC "3l/min/kg" during 24 hours. Conditions of measurements: Primary endpoint: Proportion of failure in both arms during the first 24 hours. Failure criteria: A raise of the Clinical score for respiratory distress (mWCAS) (1 point) or respiratory rate (10/min /H0 and above 60/min) or discomfort (EDIN) (1point /H0 and above 4) or apnea. Secondary outcomes: Assessment at H1, H12, H24 of mWCAS, respiratory and heart rate, EDIN score, skin lesions, FiO2 required to achieve an oxygen saturation between 94 and 97%, transcutaneous PCO2 (correlated to an initial gas analysis), Report SpO2 / FiO2 Statistic: Intention to treat Analysis. Expected number of patients: 135 per arm: 270 children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | treatment by 2l/min/kg in High Flow Nasal cannula (HFNC) | |
| DEVICE | treatment by 3l/min/kg in High Flow Nasal cannula (HFNC) |
Timeline
- Start date
- 2016-11-02
- Primary completion
- 2017-03-17
- Completion
- 2018-03-01
- First posted
- 2016-07-07
- Last updated
- 2024-05-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02824744. Inclusion in this directory is not an endorsement.